USX:CERE - Cerevel Therapeutics Holdings, Inc Cerevel Therapeutics Holdings,
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
   
Add Alert 


Yahoo Finance
Balance Sheet Cash Flow Key Ratios Personalized

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2019 Q4 2020 Q1 2020 Q3 2020 Q4 2021 Q1 Graph
Total Revenue 0
-
0
-
0
-
0
-
0
-
Cost of Revenue - - - - -
Gross Profit - - - - -
Total Expenses 83.46M
-
37.7M
-54.8%
2.97M
-92.1%
149.12M
4912.9%
161.99M
8.6%
Operating Expense 83.46M
-
37.7M
-54.8%
2.97M
-92.1%
149.12M
4912.9%
161.99M
8.6%
Operating Income -83.46M
-
-37.7M
-
-2.97M
-
-149.12M
-
-161.99M
-
Net Income (Cont Operations) -128.39M
-
-53.21M
-
- - -149.91M
-
Net Income -128.39M
-
-53.21M
-
-2.89M
-
-152.14M
-
-149.91M
-
Diluted Net Income -128.39M
-
-53.21M
-
-2.89M
-
-152.14M
-
-149.91M
-
Basic EPS -1.01
-
-0.419
-
-0.023
-
-2.01
-
-1.177
-
Diluted EPS -1.01
-
-0.419
-
-0.023
-
-2.01
-
-1.177
-
Values are in USD whenever applicable | Fiscal year ends on December 31
Powered by Morningstar